Bone mineral density, serum insulin‐like growth factor I, and bone turnover markers in viral cirrhosis

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Hepatology

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/HEP.510280315PMID 9731561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis.

  1997cited by this paper
• Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus

  1996cited by this paper
• Molecular basis and clinical application of biological markers of bone turnover.

  1996cited by this paper
• Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease

  1995cited by this paper
• Effect of acute alcohol ingestion on mineral metabolism and osteoblastic function.

  1995cited by this paper
• Effects of alcohol and liver cirrhosis on the GH-IGF-I axis.

  1995cited by this paper
• New markers of bone metabolism: clinical use in metabolic bone disease.

  1995cited by this paper
• Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis.

  1994cited by this paper
• Growth hormone‐dependent insulin‐like growth factor binding protein is a major determinant of bone mineral density in healthy men

  1994cited by this paper
• Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism.

  1993cited by this paper
• Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis

  1993cited by this paper
• Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.

  1993cited by this paper
• Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's disease

  1993cited by this paper
• Bone Mineral Density in the Spanish Population measured by dual X ray absorptiometry (DEXA)

  1992cited by this paper
• Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics.

  1992cited by this paper
• Hydroxypyridinium collagen cross‐links in human liver fibrosis: Study of alveolar echinococcosis

  1992cited by this paper
• Dehydroepiandrosterone sulfate and other possible influencing factors that modulate sex hormone-binding globulin levels in the hirsute patient.

  1992cited by this paper
• Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.

  1991cited by this paper
• In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats.

  1991cited by this paper
• Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.

  1991cited by this paper
• Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH.

  1991cited by this paper
• Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis

  1991cited by this paper
• Decreased serum osteocalcin levels in patients with liver cirrhosis.

  1990cited by this paper
• Alcohol decreases serum osteocalcin in a dose-dependent way in normal subjects

  1990cited by this paper
• Osteoporosis and skeletal fractures in chronic liver disease.

  1990cited by this paper
• 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene.

  1989cited by this paper
• Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease.

  1989cited by this paper
• Bone involvement in primary hemochromatosis and alcoholic cirrhosis.

  1989cited by this paper
• Hepatic osteodystrophy: Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease

  1989cited by this paper
• Ethanol reduces bone formation and may cause osteoporosis.

  1989cited by this paper
• Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?

  1989cited by this paper
• Quantitative assessment of collagen crosslinks in dissected predentin and dentin.

  1988cited by this paper
• Bone isoenzyme of serum alkaline phosphatase measured with wheat-germ agglutinin.

  1988cited by this paper
• Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.

  1988cited by this paper
• Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae.

  1988cited by this paper
• Deranged bone mineral metabolism in chronic alcoholism.

  1987cited by this paper
• Low bone turnover state in primary biliary cirrhosis

  1987cited by this paper
• Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis.

  1987cited by this paper
• Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

  1986cited by this paper
• Bone and mineral metabolism and chronic alcohol abuse.

  1986cited by this paper
• Bone disease in alcohol abuse.

  1986cited by this paper
• Bone loss and reduced osteoblast function in primary biliary cirrhosis.

  1985cited by this paper
• Weight loss in mildly to moderately obese patients with obstructive sleep apnea.

  1985cited by this paper
• Bone disease in alcohol abuse.

  1985cited by this paper
• Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

  1982cited by this paper
• Chronic alcoholism.

  1974cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism

  year unknowncited by this paper

• Bone and liver diseases

  2026cites this paper
• Potential Physiological Factors Underlying Diagnostic Discrepancies between MRI-based Cervical Vertebral Bone Quality Scores and dual-energy X-ray Absorptiometry T-scores.

  2025cites this paper
• Liver function linked to bone health: A bibliometric of the liver-bone axis

  2025cites this paper
• Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis

  2025cites this paper
• Screening of genes co-associated with osteoporosis and chronic HBV infection based on bioinformatics analysis and machine learning

  2024cites this paper
• Emerging role of liver-bone axis in osteoporosis

  2024cites this paper
• Extrahepatic Manifestations of Chronic Hepatitis C Virus (HCV) Infection

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• High bone fracture risk in a large modern cohort of liver transplant recipients

  2024cites this paper
• Changes in thoracic radio density after living donor liver transplantation

  2024cites this paper
• Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX® as a Screening Tool

  2023cites this paper
• Vitamin D status & bone health in patients with liver cirrhosis

  2023cites this paper
• SIRT2 regulates extracellular vesicle-mediated liver–bone communication

  2023cites this paper
• Prevalence of Osteoporosis in Cirrhosis: A Systematic Review and Meta-Analysis

  2023cites this paper
• Decreasing Rates of Fracture-Related Hospitalization With Primary Biliary Cholangitis: Insights From the Nationwide Inpatient Sample

  2022cites this paper
• Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?

  2022cites this paper
• Impact of Liver Cirrhosis on Bone Metabolism

  2022cites this paper
• Management of Stabil Vertebra Fractures in Patients Underwent Liver Transplantation

  2021influential citation
• Prevalence and predictors of post-liver transplantation metabolic bone diseases

  2021cites this paper
• Human immunodeficiency virus and osteoporosis

  2021cites this paper
• Os et foie

  2021cites this paper
• Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial

  2021cites this paper
• Determining Bone Turnover Status in Patients With Chronic Liver Disease

  2021cites this paper
• Post-surgery cholecystectomy, hepatectomy, and pancreatectomy patients increase the risk of osteoporotic vertebral fracture

  2020cites this paper
• Increased incidence, morbidity, and mortality in cirrhotic patients with hip fractures: A nationwide population-based study

  2020cites this paper
• Bone Health in Patients With Liver Diseases.

  2020cites this paper
• The Impact of Tenofovir Disoproxil Fumarate on Reduced Bone Mineral Density and Fractures in Liver Transplant Recipients.

  2020cites this paper
• Relationship of Serum Vitamin D with Liver Disease Severity and Bone Abnormalities in Cholestatic Children

  2020cites this paper
• بررسی رابطه اینترفرون آلفا با تراکم استخوان در بیماران مبتلا به هپاتیت C

  2020cites this paper
• Ostéodystrophie et marqueurs de remodelage osseux au cours des hépatopathies virales chroniques compensées

  2020cites this paper
• Association between osteoporosis and hepatitis B cirrhosis: a case-control study

  2020cites this paper
• Triple‐Phase Computed Tomography May Replace Dual‐Energy X‐ray Absorptiometry Scan for Evaluation of Osteoporosis in Liver Transplant Candidates

  2020cites this paper
• Risk factors for haematopoietic stem cell transplant (HSCT) associated bone loss: bone marrow transplantation associated bone loss.

  2020cites this paper
• Viral hepatitis

  2020cites this paper
• The Pharmacologic Management of Osteoporosis in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Evaluating some biochemical parameters and their correlation withviral load in patients with Hepatitis B virus, Thi-Qar, Iraq

  2020cites this paper
• Compromised bone strength in patients with alcoholic liver cirrhosis

  2020cites this paper
• Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indian patients with cirrhosis

  2020cites this paper
• Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis.

  2019cites this paper
• Metabolic Bone Disease in Gastrointestinal Disorders

  2019cites this paper
• Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial

  2019cites this paper
• BONE DENSITY IN PATIENTS WITH HEPATIC CIRRHOSIS & ITS CORRELATION WITH CHOLESTASIS AND GROWTH

  2019influential citation
• Prevalence of Osteoporosis in Liver Cirrhosis

  2019cites this paper
• Epidemiology, Diagnosis, and Management of Bone Disease in Patients with Chronic HBV Infection

  2019cites this paper
• Cirrhosis of the Liver and Incidence of associated Osteoporosis

  2019cites this paper
• OSTEOPOROSIS IN LIVER CIRRHOSIS

  2019cites this paper
• Bone Mineral Density Assessed By Dual-Energy X-Ray Absorptiometry in Patients with Cirrhosis of Liver

  2019cites this paper
• Risk of Osteoporosis Due To Liver Disease- A Case Control Study

  2019cites this paper
• Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development

  2019cites this paper
• The association between liver cirrhosis and fracture risk: A systematic review and meta‐analysis

  2018cites this paper
• Osteoporosis in primary biliary cholangitis

  2018cites this paper
• Association between pre‐sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C

  2018cites this paper
• Primary biliary cholangitis and bone disease.

  2018cites this paper
• Osteoporosis in chronic liver disease

  2018cites this paper
• THE PREVALENCE OF OSTEOPOROSIS IN PATIENTS WITH LIVER CIRRHOSIS

  2018cites this paper
• OSTEOPOROSIS IN CHRONIC LIVER DISEASE (CLD)

  2018cites this paper
• Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation

  2018cites this paper
• Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment

  2017cites this paper
• Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease

  2017cites this paper
• Bone Health and Impact of Tenofovir Treatment in Men with Hepatitis-B Related Chronic Liver Disease.

  2017cites this paper
• Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies

  2017cites this paper
• Hepatic Osteodystrophy: A Global (Re)View of the Problem.

  2017influential citation
• IGF-1 Therapy in Children with Liver Dysfunction

  2017cites this paper
• Proton pump inhibitors in liver cirrhosis: a review of benefits and harms

  2017cites this paper
• Vitamin D deficiency and osteoporosis in hemophilic children: an intermingled comorbidity

  2017cites this paper
• Crucial Role of Vitamin D in the Musculoskeletal System

  2016cites this paper
• Diagnosis and Management of Cirrhosis-Related Osteoporosis

  2016cites this paper
• Osteoporosis in liver disease: pathogenesis and management

  2016cites this paper
• Prevalence of avascular necrosis of femoral head in patients with cirrhosis of liver

  2016cites this paper
• Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination Surveys

  2016cites this paper
• Non Alcoholic Fatty Liver Disease and Bone Fractures in Patients with HIV

  2016cites this paper
• Body Composition Changes in Patients with Chronic Hepatitis C.

  2016cites this paper
• The risk of osteoporosis in patients with liver cirrhosis: a meta‐analysis of literature studies

  2016cites this paper
• Bone disease in cirrhosis

  2015cites this paper
• Association between nutritional screening via the Controlling Nutritional Status index and bone mineral density in chronic liver disease of various etiologies

  2015cites this paper
• Gastroenterology and Hepatology Research

  2015cites this paper
• Association between C-Reactive Protein, Incident Liver Cancer, and Chronic Liver Disease Mortality in the Linxian Nutrition Intervention Trials: A Nested Case–Control Study

  2015cites this paper
• Calcium and total bilirubin levels in patients co-infected with HIV and hepatitis C viruses in Lautech teaching hospital, Osogbo, South West Nigeria.

  2015cites this paper
• Effect of calcitriol supplementation and tail suspension on serum biomarkers of bone formation in rats

  2015cites this paper
• Growth hormone/insulin-like growth factor-1 axis, calciotropic hormones and bone mineral density in young patients with chronic viral hepatitis.

  2015influential citation
• The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism

  2015cites this paper
• HIV/AIDS and Bone Health: The Role of Nutrition

  2015cites this paper
• Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?

  2015cites this paper
• Chapter 80 – Late Complications and Recurrence of Disease After Transplantation

  2015cites this paper
• Endocrine manifestations of chronic HCV infection.

  2015cites this paper
• Pros and cons of fatty acids in bone biology.

  2015cites this paper
• Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis

  2015cites this paper
• Bone Disease in Patients with Cirrhosis

  2015cites this paper
• Expression of CD 38 , CD 226 , CD 39 , PD 1 on T cells in chronic hepatitis B and their correlation with serum vitamin D levels

  2015cites this paper
• Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction

  2015cites this paper
• Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C

  2015cites this paper
• THE EFFECT OF CHRONIC VIRAL HEPATITIS B AND C ON BONE MINERAL DENSITY

  2015cites this paper
• Primary Care of Patients with Cirrhosis – Current and Future Challenges

  2014cites this paper
• Fracture risk in hepatitis C virus infected persons: results from the DANVIR cohort study.

  2014cites this paper
• Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis

  2014cites this paper
• Osteoporosis and fractures after solid organ transplantation: a nationwide population-based cohort study.

  2014cites this paper
• Evidence of degraded BMD and geometry at the proximal femora in male patients with alcoholic liver cirrhosis

  2014cites this paper
• The risk of fractures among patients with cirrhosis or chronic pancreatitis.

  2014cites this paper
• Bone density in haemophilia: a single institutional cross‐sectional study

  2014cites this paper
• Osteoporosis and FRAX risk in patients with liver cirrhosis

  2014cites this paper